Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 21, 2022; 28(7): 732-744
Published online Feb 21, 2022. doi: 10.3748/wjg.v28.i7.732
Published online Feb 21, 2022. doi: 10.3748/wjg.v28.i7.732
Figure 2 Mean irritable bowel syndrome severity scoring system and Irritable bowel syndrome quality of life score at baseline and at the end of treatment by transit subtype.
A: IBS-SSS; B: IBS-QOL. Error bars denote standard deviation. aP < 0.001 versus baseline. IBS: Irritable bowel syndrome; IBS-QOL: Irritable bowel syndrome quality of life; IBS-SSS: Irritable bowel syndrome severity scoring system; C: Constipation; D: Diarrhea; M: Mixed; NS: Not significant; U: Unclassified.
- Citation: Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022; 28(7): 732-744
- URL: https://www.wjgnet.com/1007-9327/full/v28/i7/732.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i7.732